{
  "id": "172e52c4-e322-42f5-8ee1-a9a372b9c956",
  "answer": "Regeneron Pharmaceuticals, Inc. has a positive company news read. Its latest completed weekly trend is negative.",
  "status": "positive",
  "as_of": "2026-08-20T22:40:35.489508+00:00",
  "period_end": "2026-08-14",
  "scope": "company and instrument",
  "subject": {
    "type": "ticker",
    "key": "GER:RGO",
    "name": "Regeneron Pharmaceuticals, Inc. (RGO)",
    "identity": {
      "sharemaestro_id": "cdb53169-f08e-4509-9fef-82424c1bca56",
      "canonical_name": "Regeneron Pharmaceuticals, Inc.",
      "isin": null,
      "lei": null,
      "cik": null,
      "website": null,
      "aliases": [
        "RGO"
      ],
      "provider_symbols": {
        "eodhd": [
          "RGO.XETRA",
          "RGO.F",
          "RGO.DU",
          "RGO.MU",
          "RGO.HM",
          "RGO.HA",
          "RGO.BE",
          "RGO.STU"
        ],
        "yahoo": "RGO.DE",
        "market": "GER",
        "alpha_vantage": null
      },
      "same_as": []
    }
  },
  "coverage": {
    "country": "Germany",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "score": 54.0,
  "confidence": 34,
  "evidence_count": 16,
  "independent_sources": 3,
  "freshest_evidence": "2026-08-20T14:36:00+00:00",
  "previous_read": 54.0,
  "change": 0.0,
  "method_version": "public-evidence-1",
  "facts": {
    "sector": "Healthcare",
    "ticker": "RGO",
    "company": "Regeneron Pharmaceuticals, Inc.",
    "country": "Germany",
    "currency": "EUR",
    "exchange": "GER",
    "industry": "Biotechnology",
    "week_end": "2026-08-14",
    "asset_type": "equity",
    "news_count": 16,
    "trend_state": "negative",
    "latest_close": "693.599976",
    "score_change": 0.0,
    "weekly_change": 3.0,
    "evidence_status": "provisional",
    "sentiment_score": 54
  },
  "canonical_url": "https://sharemaestro.com/evidence/172e52c4-e322-42f5-8ee1-a9a372b9c956/",
  "evidence_urls": [
    {
      "label": "Company chart",
      "url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/"
    },
    {
      "label": "Technicals & Market Dynamics",
      "url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/technicals/"
    },
    {
      "label": "Technical Research Pack",
      "url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/technical-pack/"
    },
    {
      "label": "Company news sentiment",
      "url": "https://sharemaestro.com/sentiment/cdb53169-f08e-4509-9fef-82424c1bca56/"
    },
    {
      "label": "Current financial news",
      "url": "https://sharemaestro.com/newsreel/search/?ticker=RGO"
    }
  ],
  "related_research": {
    "type": "price_technicals_and_market_dynamics",
    "name": "Technicals & Market Dynamics",
    "publisher": "Sharemaestro",
    "framework": "Market Dynamics",
    "methodology": "proprietary",
    "scope": "completed-week price structure and underlying market support",
    "period_end": "2026-08-14",
    "url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/technicals/",
    "technical_pack_url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/technical-pack/",
    "technical_pack_pdf_url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/technical-pack/download.pdf",
    "technical_pack_data_url": "https://sharemaestro.com/terminal/cdb53169-f08e-4509-9fef-82424c1bca56/technical-pack/data.json",
    "description": "Sharemaestro's proprietary completed-week analysis of whether underlying market support is strengthening or weakening beneath price. It complements this company-news record and is not an input to the news score.",
    "relationship": "complementary_research",
    "included_in_news_score": false
  },
  "limitations": "This is dated market research. Coverage may be delayed, incomplete or unavailable.",
  "record_hash": "8be8743564bcbcf5c9e371b24a70366372ac23b951b18f9eef1db7a70dcacd05",
  "citation": "Sharemaestro, Regeneron Pharmaceuticals, Inc. (RGO), 2026-08-20, https://sharemaestro.com/evidence/172e52c4-e322-42f5-8ee1-a9a372b9c956/"
}